Macquarie Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Sell |
157,167
-3,781
| -2% | -$52.9K | ﹤0.01% | 1194 |
|
|
2025
Q1 | $2.17M | Buy |
160,948
+18,555
| +13% | +$250K | ﹤0.01% | 1193 |
|
|
2024
Q4 | $2.73M | Sell |
142,393
-1,002
| -0.7% | -$19.2K | ﹤0.01% | 1096 |
|
|
2024
Q3 | $3.26M | Buy |
143,395
+114,025
| +388% | +$2.59M | ﹤0.01% | 1082 |
|
|
2024
Q2 | $382K | Buy |
+29,370
| New | +$382K | ﹤0.01% | 1497 |
|
|
2018
Q2 | – | Sell |
-287
| Closed | -$30K | – | 2282 |
|
|
2018
Q1 | $30K | Buy |
+287
| New | +$30K | ﹤0.01% | 2044 |
|